DOI QR코드

DOI QR Code

Artificial oocyte activation in intracytoplasmic sperm injection cycles using testicular sperm in human in vitro fertilization

  • Kang, Hee Jung (Laboratory of Reproductive Biology and Infertility, Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine) ;
  • Lee, Sun-Hee (Laboratory of Reproductive Biology and Infertility, Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine) ;
  • Park, Yong-Seog (Laboratory of Reproductive Biology and Infertility, Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine) ;
  • Lim, Chun Kyu (Laboratory of Reproductive Biology and Infertility, Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine) ;
  • Ko, Duck Sung (Laboratory of Reproductive Biology and Infertility, Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine) ;
  • Yang, Kwang Moon (Department of Obstetrics and Gynecology, Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine) ;
  • Park, Dong-Wook (Laboratory of Reproductive Biology and Infertility, Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine)
  • Received : 2015.04.23
  • Accepted : 2015.05.27
  • Published : 2015.06.30

Abstract

Objective: Artificial oocyte activation (AOA) is an effective method to avoid total fertilization failure in human in vitro fertilization-embryo transfer (IVF-ET) cycles. AOA performed using a calcium ionophore can induce calcium oscillation in oocytes and initiate the fertilization process. We evaluated the usefulness of AOA with a calcium ionophore in cases of total fertilization failure in previous cycles and in cases of severe male factor infertility patients with non-motile spermatozoa after pentoxifylline (PF) treatment. Methods: The present study describes 29 intracytoplasmic sperm injection (ICSI)-AOA cycles involving male factor infertility at Cheil General Hospital from January 2006 to June 2013. Patients were divided into two groups (control, n=480; AOA, n=29) depending on whether or not AOA using a calcium ionophore (A23187) was performed after testicular sperm extraction-ICSI (TESE-ICSI). The AOA group was further split into subgroups according to sperm motility after PF treatment: i.e., motile sperm-injected (n=12) and non-motile sperm-injected (n=17) groups (total n=29 cycles). Results: The good embryo rate (52.3% vs. 66.9%), pregnancy rate (20.7% vs. 52.1%), and delivery rate (10.3% vs. 40.8%) were lower in the PF/AOA group than in the control group. When evaluating the effects of restoration of sperm motility after PF treatment on clinical outcomes there was no difference in fertilization rate (66.6% vs. 64.7% in non-motile and motile sperm, respectively), pregnancy rate (17.6% vs. 33.3%), or delivery rate (5.9% vs. 16.7%) between the two groups. Conclusion: We suggest that oocyte activation is a useful method to ensure fertilization in TESE-ICSI cycles regardless of restoration of sperm motility after PF treatment. AOA may be useful in selected patients who have a low fertilization rate or total fertilization failure.

Keywords

References

  1. Farhi J, Ben-Haroush A, Dresler H, Pinkas H, Sapir O, Fisch B. Male factor infertility, low fertilisation rate following ICSI and low number of high-quality embryos are associated with high order recurrent implantation failure in young IVF patients. Acta Obstet Gynecol Scand 2008;87:76-80. https://doi.org/10.1080/00016340701743074
  2. Yanagida K. Complete fertilization failure in ICSI. Hum Cell 2004; 17:187-93.
  3. Nasr-Esfahani MH, Deemeh MR, Tavalaee M. Artificial oocyte activation and intracytoplasmic sperm injection. Fertil Steril 2010;94: 520-6. https://doi.org/10.1016/j.fertnstert.2009.03.061
  4. Wall MB, Marks K, Smith TA, Gearon CM, Muggleton-Harris AL. Cytogenetic and fluorescent in-situ hybridization chromosomal studies on in-vitro fertilized and intracytoplasmic sperm injected 'failed-fertilized' human oocytes. Hum Reprod 1996;11:2230-8. https://doi.org/10.1093/oxfordjournals.humrep.a019082
  5. Dubey AK, Penzias AS, Emmi AE, Layman LC, Reindollar RH, Ducibella T. Failed fertilization after intracytoplasmic sperm injection: the extent of paternal and maternal chromatin decondensation. Fertil Steril 1997;68:714-7. https://doi.org/10.1016/S0015-0282(97)00313-0
  6. Buffone MG, Schindler K, Schultz RM. Overexpression of CDC14B causes mitotic arrest and inhibits zygotic genome activation in mouse preimplantation embryos. Cell Cycle 2009;8:3904-13. https://doi.org/10.4161/cc.8.23.10074
  7. Stricker SA. Comparative biology of calcium signaling during fertilization and egg activation in animals. Dev Biol 1999;211:157-76. https://doi.org/10.1006/dbio.1999.9340
  8. Rice A, Parrington J, Jones KT, Swann K. Mammalian sperm contain a Ca(2+)-sensitive phospholipase C activity that can generate InsP(3) from PIP(2) associated with intracellular organelles. Dev Biol 2000;228:125-35. https://doi.org/10.1006/dbio.2000.9929
  9. Saunders CM, Larman MG, Parrington J, Cox LJ, Royse J, Blayney LM, et al. PLC zeta: a sperm-specific trigger of Ca(2+) oscillations in eggs and embryo development. Development 2002;129:3533-44.
  10. Tosti E, Boni R. Electrical events during gamete maturation and fertilization in animals and humans. Hum Reprod Update 2004; 10:53-65. https://doi.org/10.1093/humupd/dmh006
  11. McLay DW, Carroll J, Clarke HJ. The ability to develop an activity that transfers histones onto sperm chromatin is acquired with meiotic competence during oocyte growth. Dev Biol 2002;241: 195-206. https://doi.org/10.1006/dbio.2001.0499
  12. Aparicio NJ, de Turner EA, Schwarzstein L, Turner D. Effect of the phosphodiesterase inhibitor Pentoxyfylline on human sperm motility. Andrologia 1980;12:49-54.
  13. Morales P, Llanos M, Yovich JL, Cummins JM, Vigil P. Pentoxifylline increases sperm penetration into zona-free hamster oocytes without increasing the acrosome reaction. Andrologia 1993;25: 359-62.
  14. Kovacic B, Vlaisavljevic V, Reljic M. Clinical use of pentoxifylline for activation of immotile testicular sperm before ICSI in patients with azoospermia. J Androl 2006;27:45-52. https://doi.org/10.2164/jandrol.05079
  15. Tash JS, Means AR. Cyclic adenosine 3',5' monophosphate, calcium and protein phosphorylation in flagellar motility. Biol Reprod 1983;28:75-104. https://doi.org/10.1095/biolreprod28.1.75
  16. Ozil JP, Banrezes B, Toth S, Pan H, Schultz RM. Ca2+ oscillatory pattern in fertilized mouse eggs affects gene expression and development to term. Dev Biol 2006;300:534-44. https://doi.org/10.1016/j.ydbio.2006.08.041
  17. Montag M, Koster M, van der Ven K, Bohlen U, van der Ven H. The benefit of artificial oocyte activation is dependent on the fertilization rate in a previous treatment cycle. Reprod Biomed Online 2012;24:521-6. https://doi.org/10.1016/j.rbmo.2012.02.002
  18. Borges E Jr, de Almeida Ferreira Braga DP, de Sousa Bonetti TC, Iaconelli A Jr, Franco JG Jr. Artificial oocyte activation with calcium ionophore A23187 in intracytoplasmic sperm injection cycles using surgically retrieved spermatozoa. Fertil Steril 2009;92:131-6. https://doi.org/10.1016/j.fertnstert.2008.04.046
  19. Tug N, Sandal S, Ozelgun B, Yilmaz B. Correlation of spermiogram profiles with DNA damage in sperm cells of infertile men: a comet assay study. Gynecol Endocrinol 2011;27:49-54. https://doi.org/10.3109/09513590.2010.487598
  20. Park YS, Kim MK, Lee SH, Cho JW, Song IO, Seo JT. Efficacy of testicular sperm chromatin condensation assay using aniline blueeosin staining in the IVF-ET cycle. Clin Exp Reprod Med 2011;38: 142-7. https://doi.org/10.5653/cerm.2011.38.3.142
  21. Bachtell NE, Conaghan J, Turek PJ. The relative viability of human spermatozoa from the vas deferens, epididymis and testis before and after cryopreservation. Hum Reprod 1999;14:3048-51. https://doi.org/10.1093/humrep/14.12.3048
  22. Chi HJ, Chung DY, Choi SY, Kim JH, Kim GY, Lee JS, et al. Integrity of human sperm DNA assessed by the neutral comet assay and its relationship to semen parameters and clinical outcomes for the IVF-ET program. Clin Exp Reprod Med 2011;38:10-7. https://doi.org/10.5653/cerm.2011.38.1.10

Cited by

  1. Effect of two assisted oocyte activation protocols used to overcome fertilization failure on the activation potential and calcium releasing pattern vol.105, pp.3, 2015, https://doi.org/10.1016/j.fertnstert.2015.11.007
  2. Improving ICSI: A review from the spermatozoon perspective vol.62, pp.6, 2016, https://doi.org/10.1080/19396368.2016.1229365
  3. Strategies to improve fertilisation rates with assisted conception: a systematic review vol.21, pp.4, 2015, https://doi.org/10.1080/14647273.2017.1324182
  4. Effects of assisted oocyte activation with calcium- ionophore and strontium chloride on in vitro ICSI outcomes vol.21, pp.11, 2018, https://doi.org/10.22038/ijbms.2018.30422.7331
  5. Artificial oocyte activation: physiological, pathophysiological and ethical aspects vol.65, pp.1, 2019, https://doi.org/10.1080/19396368.2018.1516000
  6. Pregnancy and neonatal outcomes of artificial oocyte activation in patients undergoing frozen-thawed embryo transfer: a 6-year population-based retrospective study vol.300, pp.4, 2015, https://doi.org/10.1007/s00404-019-05298-3
  7. Pentoxifylline treatment of frozen pig sperm affects sperm motility and fetal numbers vol.47, pp.3, 2020, https://doi.org/10.7744/kjoas.20200053
  8. Sperm Selection Procedures for Optimizing the Outcome of ICSI in Patients with NOA vol.10, pp.12, 2015, https://doi.org/10.3390/jcm10122687